APA Style

MJ, M. (). Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma . : .

MLA Style

MJ, Martin. "Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma". : , . THERAPEUTIC CLASS.